End Result ? Without ZONING there is no Federal remedy or
End Result ? Without ZONING there is no Federal remedy or claim.
The law says we have no Zoning. No appellate court will rule otherwise because Bill dropped the case.
The OMB hearing was a sure thing, we get back our zoning to produce MMJ. Well established law applies and Governing case law exists. ( Remember the Go- Cart track case ) ?
With Zoning we shareholders have a stake and are still in the game. With Zoning we now can petition the federal gov. for a license and or Monetary Damages.
With Zoning Cen Biotech could merge, sublease, lease, or sell the parcel as a MMJ zoned parcel for production.
With Zoning ruled in our favor we shareholders are still in the GAME.
HONOR is ENERGY, positive ENERGY,
it has no FACE, SO what's FUELING the NEGITIVE ?
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Hims & Hers Revenue Challenges Amid Stock Decline In recent trading sessions, Hims & Hers Health reported notable stock fluctuations as the company unveiled a decline in revenue per customer linked to its customization of GLP-1 medications for weight loss. This announcement caused an almost 11% drop in the stock price. Impacts of Collaboration Termination This steep...
Continue Reading
Entrée Resources Ltd. Overview Entrée Resources Ltd. (TSX: ETG; OTCQB: ERLFF), a reputable Canadian mining company focused on the Oyu Tolgoi project, has announced its interim financial results for the third quarter of 2025. This announcement sheds light on its ongoing operations and future plans, emphasizing the company's significant role in one of the world's largest...
Continue Reading
Sipping on the Extraordinary: LA Wine Soiree When was the last time you had a glass of wine that truly feels like you've unlocked a treasure chest? That's what LearnAboutWine.com is going for with their bucket list wine dinners in Los Angeles. Imagine tasting some of the world's most coveted bottles, all served with a level of polish that screams high-end dining. Led by...
Continue Reading
BioLife Solutions Announces $73 Million Sale of SciSafe In a significant move aimed at reinforcing its strategic direction, BioLife Solutions, Inc. (NASDAQ: BLFS), a prominent player in the development and supply of cell processing tools and services for the cell and gene therapy market, has announced the sale of its biostorage subsidiary, SciSafe Holdings, Inc. The...
Continue Reading
Innovative Pathway Towards a Universal COVID-19 Vaccine In the wake of a global resurgence of COVID-19, Dx&Vx (DXVX) is stepping up its efforts to develop a universal vaccine aimed at providing protection against all variants of the virus. With the recent acquisition of cutting-edge technology, this next-generation vaccine is set to attract significant global interest....
Continue Reading